A barotherapy prescription recommendation system

Abstract

This invention discloses a pneumatic therapy prescription recommendation system, comprising a pre-treatment data collection module (2), a pneumatic therapy prescription recommendation module (1), a personalized prescription pre-recommendation module (15), a post-treatment data collection module (3), a prescription evaluation module (16), and a personalized prescription recommendation module (18) connected in sequence; a prescription correction module (17) is connected in parallel between the prescription evaluation module (16) and the post-treatment data collection module (3). This invention is characterized by its ability to comprehensively collect the patient's physiological and pathological characteristics and to provide personalized and precise treatment plans.

Description

Technical Field

[0001] This invention relates to a patient indicator collection device, and more particularly to a pneumatic therapy prescription recommendation system. Background Technology

[0002] Stroke is the leading cause of death and disability among adults in my country, characterized by five major features: high incidence, high disability rate, high mortality rate, high recurrence rate, and high economic burden. Stroke patients suffer from impaired cerebral circulation due to damage to blood vessels in the brain, resulting in decreased blood supply and impaired blood flow self-regulation, which affects the outcome of cerebral cortex function reorganization and rehabilitation training. Simultaneously, prolonged bed rest in stroke patients leads to poor blood circulation, increasing the risk of deep vein thrombosis, causing limb edema and skin tissue ischemia, and affecting muscle function.

[0003] Pneumatic compression therapy is a commonly used, non-invasive physical therapy in clinical practice, used to improve blood circulation in stroke patients, prevent deep vein thrombosis, and relieve limb edema and muscle atrophy. However, clinical prescriptions for pneumatic compression therapy typically only consider the type of illness and the presence of contraindications. It is difficult to accurately grasp the patient's specific physiological and pathological indicators. Treatment parameters, frequency, and duration rely heavily on the experience of clinicians and rehabilitation therapists, making it impossible to provide personalized and precise pneumatic compression therapy plans for patients. Therefore, existing technologies suffer from the inability to comprehensively collect patients' physiological and pathological characteristics and to provide personalized and precise pneumatic compression therapy plans. Summary of the Invention

[0004] The purpose of this invention is to provide a pneumatic therapy prescription recommendation system. This invention features the ability to comprehensively collect patients' physiological and pathological characteristics and to provide personalized and precise treatment plans.

[0005] The technical solution of the present invention is a pneumatic therapy prescription recommendation system, comprising a pre-treatment data acquisition module, a pneumatic therapy prescription recommendation module, a personalized prescription pre-recommendation module, a post-treatment data acquisition module, a prescription evaluation module, and a personalized prescription recommendation module connected in sequence; a prescription correction module is connected in parallel between the prescription evaluation module and the post-treatment data acquisition module.

[0006] In the aforementioned pneumatic therapy prescription recommendation system, the pre-treatment acquisition module includes a patient basic information acquisition unit, a vascular lesion and hemodynamic characteristic measurement unit, and a limb soft tissue force transmission capacity measurement unit; the post-treatment acquisition module includes a cerebral circulation treatment effect detection unit, a peripheral circulation treatment effect detection unit, and an adverse reaction detection unit.

[0007] In the aforementioned pneumatic therapy prescription recommendation system, the patient basic information collection unit is used to collect and record the patient's name, gender, age, medical history, contraindications for pneumatic therapy, and information on symptoms requiring pneumatic therapy.

[0008] The limb soft tissue force transmission capacity measurement unit includes the measurement of body mass index, upper limb soft tissue muscle elastic modulus, and lower limb soft tissue muscle elastic modulus.

[0009] In the aforementioned pneumatic therapy prescription recommendation system, the cerebral circulation treatment effect detection unit detects changes in the patient's cerebral hemodynamics by measuring cerebral blood flow signals, thereby detecting the cerebral circulation treatment effect.

[0010] In the aforementioned pneumatic therapy prescription recommendation system, the indices for the therapeutic effect of cerebral blood flow circulation include the activation degree of each brain region, the functional connectivity of each brain region, the effect connectivity of each brain region, and the left and right brain region lateral deviation index.

[0011] In the aforementioned pneumatic therapy prescription recommendation system, the peripheral circulation treatment effect detection unit detects changes in the patient's micro-arterial hemodynamics and large artery hemodynamics by measuring limb skin blood flow signals and arterial blood flow signals, thereby realizing the detection of peripheral circulation treatment effect.

[0012] In the aforementioned pneumatic therapy prescription recommendation system, the detection indicators for micro-arterial hemodynamics include: blood perfusion, blood cell aggregation degree, blood cell flow velocity, and multi-frequency physiological regulation activity; the detection indicators for large artery hemodynamics include: peak systolic velocity, end-diastolic velocity, mean velocity, pulsatility index, and resistance index.

[0013] In the aforementioned pneumatic therapy prescription recommendation system, the adverse reactions tested in the adverse reaction detection unit include pressure intolerance, hypoxia symptoms, and respiratory abnormalities.

[0014] In the aforementioned pneumatic therapy prescription recommendation system, the personalized prescription pre-recommendation module makes personalized recommendations for pneumatic therapy prescriptions based on the patient's physiological and pathological indicators collected by the pre-treatment acquisition module.

[0015] In the aforementioned pneumatic therapy prescription recommendation system, the prescription evaluation module analyzes the adverse reaction and treatment effect data collected by the post-treatment data collection module and generates suggestions for modifying the pneumatic therapy prescription.

[0016] Compared with existing technologies, this invention comprises a pre-treatment data collection module, a pneumatic therapy prescription recommendation module, a personalized prescription pre-recommendation module, a post-treatment data collection module, a prescription evaluation module, a personalized prescription recommendation module, and a prescription correction module. This allows for comprehensive collection of the patient's physiological and pathological characteristics. By collecting data on the patient's vascular lesions, hemodynamic characteristics, and limb soft tissue force transmission capabilities before treatment, doctors or rehabilitation therapists can develop personalized and precise pneumatic therapy plans. Furthermore, by collecting data on the patient's cerebral circulation and peripheral circulation treatment effects after treatment, doctors can adjust the pneumatic therapy plan in real time, thereby effectively improving the accuracy of pneumatic therapy. In summary, this invention features comprehensive collection of the patient's physiological and pathological characteristics and the ability to provide personalized and precise treatment plans. Attached Figure Description

[0017] Figure 1 This is a flowchart illustrating the present invention;

[0018] Figure 2 This is a structural view of a device for measuring the elastic modulus of soft tissue muscles.

[0019] Figure 3 yes Figure 2 A magnified view of a portion of the image.

[0020] The labels in the attached diagram are as follows: 1-Control module, 2-Pre-treatment data acquisition module, 3-Post-treatment data acquisition module, 4-Vertical lifting support, 5-Measurement platform, 6-Arc-shaped support, 7-Magnet, 8-Magnetic body, 9-Axial movement mechanism, 10-Electric lifting rod, 11-Point shear wave elastography, 12-Telescopic rod, 13-Protective sleeve, 14-Spring, 15-Personalized prescription pre-recommendation module, 16-Prescription evaluation module, 17-Prescription correction module, 18-Personalized prescription recommendation module, 401-Fixed base, 402-Lifting telescopic rod, 403-Hydraulic lifting rod, 404-Support seat. Detailed Implementation

[0021] The present invention will be further described below with reference to the accompanying drawings and embodiments, but this should not be construed as limiting the present invention.

[0022] Example. A pneumatic therapy prescription recommendation system, configured as follows: Figures 1 to 3 As shown, it includes a pre-treatment data acquisition module 2, a pneumatic therapy prescription recommendation module 1, a personalized prescription pre-recommendation module 15, a post-treatment data acquisition module 3, a prescription evaluation module 16, and a personalized prescription recommendation module 18 connected in sequence; a prescription correction module 17 is connected in parallel between the prescription evaluation module 16 and the post-treatment data acquisition module 3.

[0023] The pre-treatment acquisition module 2 includes a patient basic information acquisition unit, a vascular lesion and hemodynamic characteristic measurement unit, and a limb soft tissue force transmission capacity measurement unit; the post-treatment acquisition module 3 includes a cerebral circulation treatment effect detection unit, a peripheral circulation treatment effect detection unit, and an adverse reaction detection unit.

[0024] The patient basic information collection unit is used to collect and record the patient's name, gender, age, medical history, contraindications for pneumatic barotherapy, and information on symptoms requiring pneumatic barotherapy.

[0025] The limb soft tissue force transmission capacity measurement unit includes the measurement of body mass index, upper limb soft tissue muscle elastic modulus, and lower limb soft tissue muscle elastic modulus.

[0026] The elastic modulus of the soft tissue muscles of the upper limb and the lower limb are both measured using a soft tissue muscle elastic modulus measuring device. The soft tissue muscle elastic modulus measuring device includes a vertical lifting support 4, a measuring platform 5 on the vertical lifting support 4, an arc-shaped support 6 on the measuring platform 5, one end of the arc-shaped support 6 is hinged to the measuring platform 5, and a magnet 7 is embedded in the other end of the arc-shaped support 6. A magnetic body 8 that cooperates with the magnet 7 is provided on the measuring platform 5. An axial moving mechanism 9 is provided on the inner top wall of the arc-shaped support 6, an electric lifting rod 10 is provided below the axial moving mechanism 9, and a point shear wave elastography instrument 11 is provided at the lower end of the electric lifting rod 10.

[0027] Below the electric lifting rod 10, there are also telescopic rods 12 located on both sides of the point shear wave elastic imager 11. A protective sleeve 13 is provided between the two telescopic rods 12. The protective sleeve 13 has a through hole in the middle that is opposite to the point shear wave elastic imager 11. A spring 14 is sleeved on the telescopic rod 12.

[0028] The vertical lifting support 4 includes a fixed base 401, with lifting telescopic rods 402 at both ends above the fixed base 401, a hydraulic lifting rod 403 between the two lifting telescopic rods 402, a support seat 404 above the hydraulic lifting rod 403, and the two ends below the support seat 404 fixed to the lifting telescopic rods 402.

[0029] The measuring platform 5 and the vertical lifting support 4 are rotatably connected, and the rotation angle is 90°.

[0030] Furthermore, this invention employs a soft tissue muscle elastic modulus measuring device to measure the soft tissue muscle elastic modulus of the upper and lower limbs. Utilizing a vertical lifting support and a rotating measuring platform, it can meet the measurement requirements of soft tissue muscle elastic modulus at different locations and angles of the human body. Simultaneously, by incorporating an axial movement mechanism and an electric lifting rod on the arc-shaped support, it can adapt to the size requirements of the upper and lower limbs and also measure the soft tissue muscle elastic modulus at multiple locations. A protective sleeve is included to protect the point-type shear wave elastography instrument.

[0031] The brain circulation treatment effect detection unit detects changes in the patient's cerebral hemodynamics by measuring cerebral blood flow signals, thereby detecting the effect of brain circulation treatment.

[0032] The indices for the therapeutic effect of cerebral blood flow circulation include the activation level of each brain region, the functional connectivity of each brain region, the effect connectivity of each brain region, and the left-right brain region lateral deviation index.

[0033] The peripheral circulation treatment efficacy detection unit measures changes in micro-arterial hemodynamics and large arterial hemodynamics by measuring limb skin blood flow signals and arterial blood flow signals, thereby detecting the efficacy of peripheral circulation treatment.

[0034] The indicators for detecting microarterial hemodynamics include: blood perfusion, blood cell aggregation, blood cell velocity, and multi-frequency physiological regulation activities; the indicators for detecting large artery hemodynamics include: peak systolic velocity, end-diastolic velocity, mean velocity, pulsatility index, and resistance index.

[0035] The measuring platform has an axial arc-shaped limiting groove in the middle.

[0036] The axial movement mechanism can be driven by a lead screw.

[0037] The protective sleeve is also equipped with an infrared sensor. When the protective sleeve rises under pressure to the point where the point shear wave elastomer is flush with the outer end of the through hole, the point shear wave elastomer blocks the infrared light of the infrared sensor. After receiving the signal, the electric lifting rod stops descending.

[0038] The working process of the soft tissue muscle elastic modulus measuring device is as follows: Adjust the height of the vertical lifting frame to the designated position according to the different body parts and the patient's height. When measuring the upper limb, rotate the measuring platform to a position perpendicular to the vertical lifting frame; when measuring the lower limb, rotate the measuring platform to a position parallel to the vertical lifting frame. Then, open the arc-shaped support, place the body part to be tested onto the measuring platform, close the arc-shaped support, and start the electric lifting rod to lower the point-type shear wave elastography device and protective sleeve. The protective sleeve first contacts the limb, and the electric lifting rod continues to descend until the point-type shear wave elastography device is flush with the lower end of the protective sleeve, allowing the device to fit against the limb for testing. Simultaneously, the axial movement mechanism moves the point-type shear wave elastography device, completing the testing of multiple positions on the limb.

[0039] The control and analysis module includes a pneumatic therapy prescription recommendation algorithm, which matches, adjusts and recommends pneumatic therapy intervention parameters in the existing pneumatic therapy prescription knowledge base based on indicators such as contraindications, vascular calcification, treated conditions, degree of vascular lesions and hemodynamic characteristics, and the force transmission capacity of soft tissues in the limbs.

[0040] Personalized prescription pre-recommendation refers to the personalized recommendation of pneumatic compression therapy prescriptions based on the patient's physiological and pathological indicators and existing pneumatic compression therapy prescription recommendation algorithms.

[0041] The prescription evaluation module refers to the assessment of adverse reactions and treatment effects through pneumatic therapy prescription testing, which is then reviewed and modified by doctors, who provide suggestions for modification of the pneumatic therapy prescription.

[0042] Adverse reactions tested in the adverse reaction detection unit include pressure intolerance, hypoxia symptoms, and respiratory abnormalities.

Claims

1. A pneumatic barotherapy prescription recommendation system, characterized in that: It includes a pre-treatment data collection module (2), a pneumatic therapy prescription recommendation module (1), a personalized prescription pre-recommendation module (15), a post-treatment data collection module (3), a prescription evaluation module (16), and a personalized prescription recommendation module (18) connected in sequence; a prescription correction module (17) is connected in parallel between the prescription evaluation module (16) and the post-treatment data collection module (3). The pre-treatment acquisition module (2) includes a patient basic information acquisition unit, a vascular lesion and hemodynamic characteristic measurement unit, and a limb soft tissue force transmission capacity measurement unit; the post-treatment acquisition module (3) includes a cerebral circulation treatment effect detection unit, a peripheral circulation treatment effect detection unit, and an adverse reaction detection unit; The patient basic information collection unit is used to collect and record the patient's name, gender, age, medical history, contraindications for pneumatic barotherapy, and information on symptoms requiring pneumatic barotherapy. The limb soft tissue force transmission capacity measurement unit includes the measurement of body mass index, upper limb soft tissue muscle elastic modulus, and lower limb soft tissue muscle elastic modulus. The elastic modulus of the soft tissue muscles of the upper limb and the lower limb were measured using a soft tissue muscle elastic modulus measuring device. The soft tissue muscle elastic modulus measuring device includes a vertical lifting support (4), a measuring platform (5) on the vertical lifting support (4), an arc-shaped support (6) on the measuring platform (5), one end of the arc-shaped support (6) is hinged to the measuring platform (5), and a magnet (7) is embedded at the other end of the arc-shaped support (6). A magnetic body (8) that cooperates with the magnet (7) is provided on the measuring platform (5). An axial moving mechanism (9) is provided on the inner top wall of the arc-shaped support (6), an electric lifting rod (10) is provided below the axial moving mechanism (9), and a point shear wave elastic imaging instrument (11) is provided at the lower end of the electric lifting rod (10). Below the electric lifting rod (10) are telescopic rods (12) located on both sides of the point shear wave elastic imaging instrument (11). A protective sleeve (13) is provided between the two telescopic rods (12). A through hole opposite to the point shear wave elastic imaging instrument (11) is provided in the middle of the protective sleeve (13). A spring (14) is sleeved on the telescopic rod (12). The vertical lifting bracket (4) includes a fixed base (401). Lifting telescopic rods (402) are provided at both ends above the fixed base (401). A hydraulic lifting rod (403) is provided between the two lifting telescopic rods (402). A support seat (404) is provided above the hydraulic lifting rod (403). The two ends below the support seat (404) are fixed to the lifting telescopic rods (402). The measuring platform (5) is rotatably connected to the vertical lifting bracket (4), and the rotation angle is 90°.

2. The pneumatic therapy prescription recommendation system according to claim 1, characterized in that: The brain circulation treatment effect detection unit detects changes in the patient's cerebral hemodynamics by measuring cerebral blood flow signals, thereby detecting the effect of brain circulation treatment.

3. The pneumatic therapy prescription recommendation system according to claim 2, characterized in that: The indices for the therapeutic effect of cerebral blood flow circulation include the activation level of each brain region, the functional connectivity of each brain region, the effect connectivity of each brain region, and the left-right brain region lateral deviation index.

4. The pneumatic therapy prescription recommendation system according to claim 1, characterized in that: The peripheral circulation treatment efficacy detection unit measures changes in micro-arterial hemodynamics and large arterial hemodynamics by measuring limb skin blood flow signals and arterial blood flow signals, thereby detecting the efficacy of peripheral circulation treatment.

5. The pneumatic therapy prescription recommendation system according to claim 4, characterized in that: The indicators for detecting microarterial hemodynamics include: blood perfusion, blood cell aggregation, blood cell velocity, and multi-frequency physiological regulation activities; the indicators for detecting large artery hemodynamics include: peak systolic velocity, end-diastolic velocity, mean velocity, pulsatility index, and resistance index.

6. The pneumatic therapy prescription recommendation system according to claim 1, characterized in that: Adverse reactions tested in the adverse reaction detection unit include pressure intolerance, hypoxia symptoms, and respiratory abnormalities.

7. The pneumatic therapy prescription recommendation system according to claim 1, characterized in that: The personalized prescription pre-recommendation module (15) makes personalized recommendations for the prescription of pneumatic therapy based on the patient's physiological and pathological indicators collected by the pre-treatment collection module (2).

8. The pneumatic therapy prescription recommendation system according to claim 1, characterized in that: The prescription evaluation module (16) analyzes the adverse reaction and treatment effect data collected by the post-treatment collection module and generates suggestions for modifying the pneumatic therapy prescription.

Images